Understanding how cells manage protein degradation under stress

Proteasome homeostasis and substrate prioritization

['FUNDING_OTHER'] · UNIVERSITY OF KANSAS MEDICAL CENTER · NIH-10929292

This study is looking at how our cells manage to break down damaged proteins when they’re under stress, like from heat or other challenges, and it aims to understand how this process changes as we age or when we have diseases like cancer or neurodegenerative disorders.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF KANSAS MEDICAL CENTER (nih funded)
Locations1 site (KANSAS CITY, UNITED STATES)
Trial IDNIH-10929292 on ClinicalTrials.gov

What this research studies

This research investigates how cells adjust their proteasome capacity to degrade proteins when faced with stressors like heat or oxidative stress. By examining the mechanisms behind proteasome regulation and assembly, the study aims to uncover how these processes are affected by aging and diseases such as neurodegenerative disorders and cancer. The research will utilize various cellular models to explore the responses of proteasomes to different stress conditions, providing insights into their role in maintaining cellular health.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals experiencing age-related conditions or neurodegenerative diseases.

Not a fit: Patients with acute, non-degenerative conditions unrelated to proteasome function may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing cellular function and resilience in aging and disease.

How similar studies have performed: Previous research has shown promising results in understanding proteasome function in stress responses, indicating that this approach has potential for significant findings.

Where this research is happening

KANSAS CITY, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Cancers

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.